Facilitated Data Relay and Effects on Treatment of Severe Aortic Stenosis in Europe.


Journal

Journal of the American Heart Association
ISSN: 2047-9980
Titre abrégé: J Am Heart Assoc
Pays: England
ID NLM: 101580524

Informations de publication

Date de publication:
10 2019
Historique:
entrez: 25 9 2019
pubmed: 25 9 2019
medline: 21 10 2020
Statut: ppublish

Résumé

Background Many patients with severe aortic stenosis are referred late with advanced symptoms or inappropriately denied intervention. The objective was to investigate whether a structured communication to referring physicians (facilitated data relay) might improve the rate and timeliness of intervention. Methods and Results A prospective registry of consecutive patients with severe aortic stenosis at 23 centers in 9 European countries with transcatheter as well as surgical aortic valve replacement being available was performed. The study included a 3-month documentation of the status quo (phase A), a 6-month intervention phase (implementing facilitated data relay), and a 3-month documentation of a legacy effect (phase-B). Two thousand one hundred seventy-one patients with severe aortic stenoses were enrolled (phase A: 759; intervention: 905; phase-B: 507). Mean age was 77.9±10.0 years, and 80% were symptomatic, including 52% with severe symptoms. During phase A, intervention was planned in 464/696 (67%), 138 (20%) were assigned to watchful waiting, 8 (1%) to balloon aortic valvuloplasty, 60 (9%) were listed as not for active treatment, and in 26 (4%), no decision was made. Three hundred sixty-three of 464 (78%) patients received the planned intervention within 3 months. Timeliness of the intervention improved as shown by the higher number of aortic valve replacements performed within 3 months (59% versus 51%,

Identifiants

pubmed: 31549578
doi: 10.1161/JAHA.119.013160
pmc: PMC6806053
doi:

Banques de données

ClinicalTrials.gov
['NCT02241447']

Types de publication

Comparative Study Journal Article Multicenter Study Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e013160

Références

Thorac Cardiovasc Surg. 1996 Dec;44(6):289-95
pubmed: 9021905
Circulation. 2014 Jun 10;129(23):e521-643
pubmed: 24589853
Med Care. 2006 Jul;44(7):646-57
pubmed: 16799359
Lancet. 2018 Mar 10;391(10124):960-969
pubmed: 29536860
Eur Heart J. 2013 Jun;34(21):1597-606
pubmed: 23293304
Int J Cardiol. 2009 Feb 20;132(2):240-3
pubmed: 18255174
Am J Cardiol. 2010 May 1;105(9):1339-42
pubmed: 20403489
Can J Cardiol. 2014 Oct;30(10):1162-9
pubmed: 25047363
BMC Cardiovasc Disord. 2017 Jan 5;17(1):5
pubmed: 28056819
Am Heart J. 2007 Apr;153(4):696-703
pubmed: 17383314
Heart. 2013 Mar;99(6):396-400
pubmed: 22942293
J Am Heart Assoc. 2019 Oct;8(19):e013160
pubmed: 31549578
Eur Heart J. 2017 Sep 21;38(36):2739-2791
pubmed: 28886619
Eur J Cardiothorac Surg. 2012 Oct;42(4):S1-44
pubmed: 22922698
J Am Coll Cardiol. 2017 Mar 14;69(10):1313-1346
pubmed: 28063810
Eur Heart J. 2003 Jul;24(13):1231-43
pubmed: 12831818
Circulation. 1982 Nov;66(5):1105-10
pubmed: 7127696
Gerontologist. 1970 Spring;10(1):20-30
pubmed: 5420677
Circulation. 2010 Jan 5;121(1):151-6
pubmed: 20026771
Heart. 2013 Dec;99(23):1714-6
pubmed: 23532202
J Am Soc Echocardiogr. 2017 Apr;30(4):372-392
pubmed: 28385280
Eur Heart J Cardiovasc Imaging. 2017 Feb;18(2):138-144
pubmed: 27520802
Neth Heart J. 2012 Dec;20(12):487-93
pubmed: 22864980
Ann Thorac Surg. 2014 Nov;98(5):1564-70; discussion 1570-1
pubmed: 25240781
JAMA Cardiol. 2017 Oct 1;2(10):1141-1146
pubmed: 28877303
J Am Soc Echocardiogr. 2015 Jul;28(7):795-801
pubmed: 25843026
Eur Heart J. 1988 Apr;9 Suppl E:57-64
pubmed: 3042404

Auteurs

Richard P Steeds (RP)

Queen Elizabeth Hospital & Institute of Cardiovascular Sciences University of Birmingham UK.

Matthias Lutz (M)

Department of Cardiology and Angiology University of Kiel Germany.

Jeetendra Thambyrajah (J)

James Cook Hospital Middlesbrough UK.

Antonio Serra (A)

Interventional Cardiology Unit, Hospital de la Santa Creu i Sant Pau Barcelona Spain.

Eberhard Schulz (E)

Cardiology Department I University Clinic Mainz Germany.

Jiri Maly (J)

Department of Cardiovascular Surgery Institute for Clinical and Experimental Medicine Prague Czech Republic.
Department of Cardiovascular Surgery Second Faculty of Medicine Charles University Prague Czech Republic.

Marco Aiello (M)

Department of Cardiothoracic Surgery Foundation IRCCS Policlinico S.Matteo Pavia Italy.

Tanja K Rudolph (TK)

Department of Cardiology University of Cologne Heart Center Cologne Germany.

Guy Lloyd (G)

St Bartholomew's Hospital London UK.

Alessandro Santo Bortone (AS)

University of Bari Italy.

Karl Eugen Hauptmann (KE)

Krankenhaus der Barmherzigen Brüder Trier Germany.

Alberto Clerici (A)

University of Turin Italy.

Georg Delle-Karth (G)

4th Medical Department Hietzing Hospital Vienna Austria.

Johannes Rieber (J)

Herzkatheterlabor Nymphenburg and Department of Cardiology University of Munich Germany.

Ciro Indolfi (C)

Division of Cardiology and URT CNR of IFC University Magna Graecia Catanzaro Italy.

Massimo Mancone (M)

Sapienza University of Rome Italy.

Loic Belle (L)

Centre Hospital d'Annecy France.

Alexander Lauten (A)

German Centre for Cardiovascular Research (DZHK) University Heart Center & Charité Berlin Germany.

Martin Arnold (M)

Department of Cardiology University Hospital Erlangen Germany.

Berto J Bouma (BJ)

University of Amsterdam Netherlands.

Cornelia Deutsch (C)

Institute for Pharmacology and Preventive Medicine Cloppenburg Germany.

Jana Kurucova (J)

Edwards Lifesciences Nyon Switzerland.

Martin Thoenes (M)

Edwards Lifesciences Nyon Switzerland.

Peter Bramlage (P)

Institute for Pharmacology and Preventive Medicine Cloppenburg Germany.

Norbert Frey (N)

Department of Cardiology and Angiology University of Kiel Germany.

David Messika-Zeitoun (D)

University of Ottawa Heart Institute Ottawa Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH